HYPERBARIC OXYGENATION THERAPY'S CLINICAL EFFICIENCY IN THE THERAPY OF ACUTE MYOCARDIAL INFARCTION PATIENTS

Abstract

HBO application to accompany the acute MI traditional pharmacotherapy proved to reduce MI recurrence within 2 years following in-patient discharge (19% decrease in reference group and 5.3% in test group, χ² = 5.0, р < 0.05), possible to raise the 2-year survival rate from 86.2 up to 94.7% (р = 0.047, when applying Fischer’s exact test).